NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) HCPCS · General Laboratory test
Classification Test General Laboratory Clinical Chemistry (CMS RBCS)
First observed 2014
National scale 4.21M services · est. ▲ 4.9% YoY · 488,587 FFS beneficiaries (CY2024, all-Medicare estimate) — 2.12M observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Market overview
Market Brief G0471
The whole of G0471, written up and sourced.

The Brief is a national document for G0471. Its findings page carries one finding per chapter, each opening the chapter that prints its figure and the table behind it — like these, from the United States, CY2024, the market on this page.

  1. 1Size and growth. The national market for G0471 ran ~4,205,299 all-Medicare services (estimated), 2,124,275 observed fee-for-service in CY2024. The market is up 4.9% year over year. 1 billing group and 3 clinicians bill it.
  2. 2Geography. NJ, FL, OH and IL lead the state markets — together 59% of state-market volume.
Estimated all-Medicare volume estimate
FFS + estimated MA

~4,205,299 services

2,124,275 observed fee-for-service (51%) · ~2,081,024 estimated Medicare Advantage.

Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Average charge

$25

per service, submitted list amounts — not payments · named-group basis, observed FFS
Average payment

$11

per service, Medicare paid amounts — not charges · all disclosed claims, observed FFS basis
Charge-to-payment ratio

2.4×

average list $25 vs average Medicare payment $11 per service · named-group basis
Where the market isobserved FFS services by state · CY2024
MEVTNHWA: 1005WAIDMTND: 4690NDMN: 248MNWI: 6943WIIL: 192410ILMI: 1509MINY: 95610NYMA: 17996MARI: 20073RIOR: 1324ORNV: 81281NVWYSDIAIN: 260INOH: 264055OHPA: 40915PANJ: 398851NJCT: 419CTCA: 75139CAUT: 2892UTCO: 24602CONEMO: 1382MOKYWVVA: 50302VAMD: 78018MDDEAZ: 12826AZNMKS: 26460KSAR: 13009ARTN: 8807TNNC: 10295NCSC: 5553SCDCOK: 66913OKLA: 3875LAMS: 5622MSAL: 15870ALGA: 63809GAHI: 1642HIAKTX: 139870TXFL: 389800FL
Shaded low→high on observed fee-for-service services billed from each state · the /stats tile grid, at national scope. Shading ranks the states rather than spacing them along the range, so neighbouring shades mean adjacent RANKS, not equal gaps — the key names the lowest and highest; each tile carries its own figure.
Which states movedservices per 1,000 FFS beneficiaries · CY2021 → CY2024
CY2021CY2024AZ: 3 → 20CA: 32 → 27CO: 39 → 60CT: 49 → 2GA: 106 → 87HI: 20 → 16KS: 126 → 76MA: 156 → 23MD: 43 → 109MI: 1 → 2MN: 2 → 1MO: 14 → 3NC: 12 → 12ND: 11 → 55NV: 339 → 340NY: 76 → 62OK: 70 → 164OR: 8 → 4PA: 42 → 35RI: 266 → 268TN: 1 → 15TX: 64 → 78WA: 18 → 2WI: 22 → 14FL: 196 → 203IL: 113 → 165NJ: 265 → 460OH: 384 → 281OH 384NJ 265FL 196IL 113460 NJ281 OH203 FL165 IL
One line per state market, 28 drawn; the 4 leading states by volume are in accent, the rest are context lines. Both columns share one scale, so a slope is real change. A RATE against each state’s own fee-for-service population — assumption-free, and no all-Medicare estimate is used or implied. CY2021 is the left period because CY2020 is the pandemic year and a slope off it would read as growth almost everywhere. 8 states with a rate in only one of the two years are not drawn.

Open a state market: NJ · FL · OH · IL · TX · NY · NV · MD · CA · OK · GA · VA — the group ranking lives in the Provider groups tab. Territories bill too; the tile grid draws the 50 states and DC.

Browse Medicare billing by specialty →